Osteoporosis & Breast Cancer R San Diego, CA - 92121

Osteoporosis & Breast Cancer R is categorized under Family Practice Doctors in San Diego, CA and active since 2004.

Osteoporosis & Breast Cancer R was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Larry Truesdale at the company’s single location by writing to 3550 General Atomics Court, San Diego, California CA 92121 or by phoning (858) 909-5123. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Osteoporosis & Breast Cancer R
Contact Person: Larry Truesdale
Address: 3550 General Atomics Court, San Diego, California 92121
Phone Number: (858) 909-5123
Annual Revenue (USD): $100.000 to $499.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Family Practice Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Osteoporosis & Breast Cancer R was started in 2004 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Larry Truesdale for inquiries that concern Osteoporosis & Breast Cancer R by calling the company number (858) 909-5123, as your correspondence is most welcome. Additionally, the physical location of the single location of Osteoporosis & Breast Cancer R can be found at the coordinates 32.894266,-117.237629 as well as the street address 3550 General Atomics Court in San Diego, California 92121.

For its online presence, you may visit Osteoporosis & Breast Cancer R’s website at and engage with its social media outlets through on Twitter and on Facebook.